| P50 | author | Lara A Kahale | Q59393167 |
| | Hneine Brax | Q117264400 |
| | Racha Fadlallah | Q124454239 |
| | Lina Al-Khaled | Q124454253 |
| | Hala Nas | Q124454254 |
| | Dana Naamani | Q124454260 |
| | Ihsan Hammoura | Q124454261 |
| | Elie A Akl | Q29838958 |
| | Fadi El-Jardali | Q29839007 |
| P2860 | cites work | Interactions between pharmaceutical representatives and doctors in training. A thematic review | Q24549713 |
| | Restrictions on interactions between doctors and industry could ultimately hurt patients | Q26824114 |
| | Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review | Q28475841 |
| | United States private-sector physicians and pharmaceutical contract research: a qualitative study | Q28481515 |
| | Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation | Q28543449 |
| | Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012 | Q28552890 |
| | How should doctors disclose conflicts of interest to patients? A focus group investigation | Q48050148 |
| | Everything you need to know about the Sunshine Act. | Q48197749 |
| | Do gifts from the pharmaceutical industry affect trust in physicians? | Q48379630 |
| | Assessing stakeholder opinion on relations between cancer patient groups and pharmaceutical companies in Europe | Q48488622 |
| | Orthopaedic surgeons and the device industry: skeletons in the closet | Q48539345 |
| | Orthopaedic surgeons and the medical device industry: the threat to scientific integrity and the public trust | Q48873589 |
| | Medicalizing mental health: a phenomenological alternative | Q49072211 |
| | The surgeon as a consultant for medical device manufacturers: what do our patients think? | Q50872053 |
| | Effect of educational interventions and medical school policies on medical students' attitudes toward pharmaceutical marketing practices: a multi-institutional study. | Q51005486 |
| | What patients think about promotional activities of pharmaceutical companies in Turkey. | Q51930203 |
| | Attitudes of physicians and public to pharmaceutical industry 'gifts'. | Q53065999 |
| | Patients' awareness of and attitudes toward gifts from pharmaceutical companies to physicians. | Q53102533 |
| | Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors. | Q53107305 |
| | Patients expect transparency in doctors' relationships with the pharmaceutical industry. | Q53114047 |
| | Standards of professionalism on orthopaedist-industry conflicts of interest. | Q53166326 |
| | The limits of disclosure: what research subjects want to know about investigator financial interests. | Q53215231 |
| | Relationships with industry: critical for new technology or an unnecessary evil? | Q53237258 |
| | Conflict of interest and the public trust. | Q53509444 |
| | Public Perceptions of Physician–Pharmaceutical Industry Interactions: A Systematic Review | Q57589454 |
| | Patients' Views on Financial Conflicts of Interest in Cancer Research Trials | Q58376051 |
| | Patient perceptions of physician acceptance of gifts from the pharmaceutical industry | Q72144983 |
| | Regulating academic-industrial research relationships--solving problems or stifling progress? | Q81180892 |
| | Out of joint: the story of the ASR | Q84102602 |
| | Restoring the pharmaceutical industry's reputation | Q85731273 |
| | Scope and impact of financial conflicts of interest in biomedical research: a systematic review | Q29616086 |
| | Disclosure of financial conflicts of interest: an evaluation of orthopaedic surgery patients' understanding | Q30532662 |
| | Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention? | Q33611364 |
| | Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia | Q33759116 |
| | Physicians and the pharmaceutical industry: is a gift ever just a gift? | Q33824626 |
| | Public perceptions of physician - pharmaceutical industry interactions: a systematic review | Q33874709 |
| | Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review | Q33879845 |
| | A social science perspective on gifts to physicians from industry | Q33967036 |
| | Bioethics for clinicians: 17. Conflict of interest in research, education and patient care | Q34029847 |
| | Joint issues--conflicts of interest, the ASR hip and suggestions for managing surgical conflicts of interest | Q34073380 |
| | Patients' attitudes about gifts to physicians from pharmaceutical companies | Q34373530 |
| | Doctors and drug companies--scrutinizing influential relationships | Q34708736 |
| | A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts | Q34751748 |
| | Interventions promoting the acceptance and uptake of generic medicines: a narrative review of the literature | Q35196852 |
| | Industry and evidence-based medicine: Believable or conflicted? A systematic review of the surgical literature | Q35372675 |
| | Pharmaceutical industry gifts to physicians: patient beliefs and trust in physicians and the health care system | Q35777666 |
| | Interventional cardiology and the medical devices industry: is there a conflict of interest? | Q36057225 |
| | The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review. | Q36211957 |
| | Counterpoint: physician-industry relationships can be ethically established, and conflicts of interest can be ethically managed | Q36818585 |
| | Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients | Q36904068 |
| | Motives, beliefs and attitudes towards waterpipe tobacco smoking: a systematic review. | Q36996871 |
| | To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships? | Q37022798 |
| | Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation | Q37138895 |
| | The impact of disclosing financial ties in research and clinical care: a systematic review | Q37737486 |
| | Pitfalls in the publication of scientific literature: a road map to manage conflict of interest and other ethical challenges | Q37789742 |
| | Demand-side policies to encourage the use of generic medicines: an overview | Q38080914 |
| | Does source of funding and conflict of interest influence the outcome and quality of spinal research? | Q38162678 |
| | Patients' views on surgeons' financial conflicts of interest | Q39484166 |
| | Physician-industry conflict of interest: public opinion regarding industry-sponsored research | Q42646891 |
| | Drug industry's new code criticised for lacking teeth | Q43107738 |
| | What do Canadians think about physician-pharmaceutical industry interactions? | Q45372121 |
| | Surgeon-industry conflict of interest: survey of North Americans' opinions regarding surgeons consulting with industry | Q46166952 |
| | Distributions of industry payments to Massachusetts physicians. | Q46541542 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | physician | Q39631 |
| | conflict of interest | Q211067 |
| | pharmaceutical industry | Q507443 |
| | health knowledge, attitudes and practice | Q69886933 |
| | interprofessional relations | Q69902834 |
| P304 | page(s) | e0160540 | |
| P577 | publication date | 2016-08-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review | |
| P478 | volume | 11 | |